Quarterly report pursuant to Section 13 or 15(d)

Organization and Description of Business (Details Narrative)

v3.23.1
Organization and Description of Business (Details Narrative)
Apr. 16, 2021
$ / shares
shares
Supera Pharmaceuticals Inc [Member] | Asset Purchase Agreement [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Stock issued during period, shares, acquisitions | shares 33,937,909
MyMD Pharmaceuticals (Florida), Inc [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Common stock, par value $ 0.001
Exchange ratio price per shares $ 0.7718